Scholarlink

Objectives <p>In this study, we aimed to assess the clinical efficacy of sonographic optic nerve sheath diameter (ONSD) measurements for detecting intracranial hypertension (ICH). Our objectives included evaluating its diagnostic precision compared with invasive intracranial pressure (ICP) monitoring; exploring potential sources of heterogeneity, such as measurement technique (multi vs. single-planar), population demographics (Asian vs. non-Asian), and major etiologies; and determining validated thresholds for prompt bedside ICP assessment in acute neurological crises.</p> Data sources <p>We comprehensively searched eight databases, including four in English (PubMed, Web of Science, MEDLINE®, and Embase) and four in Chinese (China National Knowledge Infrastructure [CNKI], Wanfang, VIP, and SinoMed). The search covered literature published from the inception of the databases up to May 31, 2025.</p> Study selection <p>This review includes prospective, retrospective, and case–control studies that assess the efficacy of sonographic ONSD measurement for detecting ICH, defined as an ICP exceeding 20&#xa0;mm Hg, 20&#xa0;cmH<sub>2</sub>O, 25&#xa0;cmH<sub>2</sub>O with invasive ICP measurement as the gold standard. Data Extraction: X.T. and Q.T. independently screened the studies and assessed the risk of bias using the QUADAS-2 tool.</p> Statistical analysis <p>Diagnostic accuracy was pooled using a bivariate random-effects model to generate summary receiver operating characteristic (SROC) curves. Subgroup analyses of the measurement technique, study population, and etiology were conducted. Publication bias was assessed using Deeks’ test.</p> Data synthesis <p>The decision tree analysis revealed that an ONSD ≥ 5.1&#xa0;mm is the critical diagnostic threshold for detecting intracranial hypertension. The regression tree model indicated a range of CDEI values from 0.64 to 0.95, with a root node value of 0.82 (95% CI: 0.79–0.85). The incorporation of a multiplanar assessment significantly enhanced the prediction of favorable outcomes (CDEI &gt; 0.85; <i>p</i> &lt; 0.001). Moreover, compared with a 20&#xa0;mmHg threshold, a 25&#xa0;cmH₂O threshold resulted in greater specificity (88.4% vs. 82.9%) and a higher positive likelihood ratio (LR+ 6.5 vs. 5.0). The utilization of multiplane techniques and experienced operators notably improved diagnostic accuracy, leading to a 50% reduction in missed diagnoses (LR− 0.1). Nontraumatic brain injury cases exhibited superior sensitivity (91.9% vs. 85.2%) and a 107% higher diagnostic odds ratio (63.3 vs. 30.5) than traumatic brain injury cases did.</p> Conclusions <p>Findings from this study suggest that an ONSD threshold ≥ 5.1&#xa0;mm is a promising diagnostic marker for elevated ICP (&gt; 20&#xa0;cmH₂O/mmHg or acute etiology), although external validation is needed. A multiplane evaluation improves its predictive accuracy for favorable outcomes. The developed decision model supports the use of sonographic ONSD measurement as a supplementary screening tool in emergency and critical care, particularly when invasive monitoring is unavailable. Additionally, an ONSD of approximately 6.0&#xa0;mm is a potential prognostic indicator for unfavorable outcomes, highlighting a key area for future research. These findings can only be applied after their validation through multicenter studies and the establishment of standardized measurement protocols.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sonographic optic nerve sheath diameter measurement for detecting intracranial hypertension in a suspected population: a systematic review and meta-analysis of diagnostic thresholds and influencing factors

  • 期刊论文

  • 发表日期：

    2026年4月2日

查看全文
  • Xu Wang,
  • Yanting Wen,
  • Xiaoqian Tong,
  • Qi Tang

摘要

Objectives

In this study, we aimed to assess the clinical efficacy of sonographic optic nerve sheath diameter (ONSD) measurements for detecting intracranial hypertension (ICH). Our objectives included evaluating its diagnostic precision compared with invasive intracranial pressure (ICP) monitoring; exploring potential sources of heterogeneity, such as measurement technique (multi vs. single-planar), population demographics (Asian vs. non-Asian), and major etiologies; and determining validated thresholds for prompt bedside ICP assessment in acute neurological crises.

Data sources

We comprehensively searched eight databases, including four in English (PubMed, Web of Science, MEDLINE®, and Embase) and four in Chinese (China National Knowledge Infrastructure [CNKI], Wanfang, VIP, and SinoMed). The search covered literature published from the inception of the databases up to May 31, 2025.

Study selection

This review includes prospective, retrospective, and case–control studies that assess the efficacy of sonographic ONSD measurement for detecting ICH, defined as an ICP exceeding 20 mm Hg, 20 cmH2O, 25 cmH2O with invasive ICP measurement as the gold standard. Data Extraction: X.T. and Q.T. independently screened the studies and assessed the risk of bias using the QUADAS-2 tool.

Statistical analysis

Diagnostic accuracy was pooled using a bivariate random-effects model to generate summary receiver operating characteristic (SROC) curves. Subgroup analyses of the measurement technique, study population, and etiology were conducted. Publication bias was assessed using Deeks’ test.

Data synthesis

The decision tree analysis revealed that an ONSD ≥ 5.1 mm is the critical diagnostic threshold for detecting intracranial hypertension. The regression tree model indicated a range of CDEI values from 0.64 to 0.95, with a root node value of 0.82 (95% CI: 0.79–0.85). The incorporation of a multiplanar assessment significantly enhanced the prediction of favorable outcomes (CDEI > 0.85; p < 0.001). Moreover, compared with a 20 mmHg threshold, a 25 cmH₂O threshold resulted in greater specificity (88.4% vs. 82.9%) and a higher positive likelihood ratio (LR+ 6.5 vs. 5.0). The utilization of multiplane techniques and experienced operators notably improved diagnostic accuracy, leading to a 50% reduction in missed diagnoses (LR− 0.1). Nontraumatic brain injury cases exhibited superior sensitivity (91.9% vs. 85.2%) and a 107% higher diagnostic odds ratio (63.3 vs. 30.5) than traumatic brain injury cases did.

Conclusions

Findings from this study suggest that an ONSD threshold ≥ 5.1 mm is a promising diagnostic marker for elevated ICP (> 20 cmH₂O/mmHg or acute etiology), although external validation is needed. A multiplane evaluation improves its predictive accuracy for favorable outcomes. The developed decision model supports the use of sonographic ONSD measurement as a supplementary screening tool in emergency and critical care, particularly when invasive monitoring is unavailable. Additionally, an ONSD of approximately 6.0 mm is a potential prognostic indicator for unfavorable outcomes, highlighting a key area for future research. These findings can only be applied after their validation through multicenter studies and the establishment of standardized measurement protocols.